Coastal Bridge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,838
Closed -$268K 164
2022
Q1
$268K Sell
5,838
-442
-7% -$21.1K 0.06% 125
2021
Q4
$385K Hold
6,280
0.08% 121
2021
Q3
$469K Sell
6,280
-109
-2% -$9.14K 0.11% 86
2021
Q2
$591K Buy
6,389
+92
+1% +$7.82K 0.12% 81
2021
Q1
$559K Buy
+6,297
New +$625K 0.1% 78

Other funds holding ARKG

Coastal Bridge Advisors's ARKG Position: Q2 2022 in Review

Coastal Bridge Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,838 shares — an estimated $268K sold.

Coastal Bridge Advisors first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $591K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Coastal Bridge Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Coastal Bridge Advisors sold 5,838 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $268K.
  • Coastal Bridge Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
  • Coastal Bridge Advisors's ARK Genomic Revolution ETF position peaked at $591K in Q2 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Coastal Bridge Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.